Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Harrison

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Journal of Medicinal Chemistry|November 11, 2005
7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal modelsRobert W Carling, Andrew Madin, Alec Guiblin, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2022
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation PhenotypesP Jane McDowell, John Busby, Catherine E Hanratty, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 9, 2023
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by SexMatthew C Eastwood, John Busby, David J Jackson, et al.
Thorax|July 25, 2015
Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)Liam G Heaney, Ratko Djukanovic, Ashley Woodcock, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Journal of Medicinal Chemistry|November 11, 2005
7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal modelsRobert W Carling, Andrew Madin, Alec Guiblin, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2022
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation PhenotypesP Jane McDowell, John Busby, Catherine E Hanratty, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 9, 2023
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by SexMatthew C Eastwood, John Busby, David J Jackson, et al.
Thorax|July 25, 2015
Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)Liam G Heaney, Ratko Djukanovic, Ashley Woodcock, et al.
Pageof 8